{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T05:02:13Z","timestamp":1774587733040,"version":"3.50.1"},"reference-count":28,"publisher":"Society of Nuclear Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2025,1,14]]},"published-print":{"date-parts":[[2025,3]]},"DOI":"10.2967\/jnumed.124.269319","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T18:45:16Z","timestamp":1738867516000},"page":"366-372","source":"Crossref","is-referenced-by-count":5,"title":["<sup>99m<\/sup>Tc-MIP-1404 SPECT\/CT Companion Diagnostic for<sup>177<\/sup>Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer"],"prefix":"10.2967","volume":"66","author":[{"given":"Thorsten","family":"Derlin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liam","family":"Widjaja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina Natascha","family":"Harke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Czerner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desiree","family":"Weiberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias L.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank M.","family":"Bengel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1602","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"key":"2025030410451226000_66.3.366.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107322"},{"key":"2025030410451226000_66.3.366.2","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/pros.23974","article-title":"Influence of short-term dexamethasone on the efficacy of 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer","volume":"80","author":"Derlin","year":"2020","journal-title":"Prostate."},{"key":"2025030410451226000_66.3.366.3","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.267951"},{"key":"2025030410451226000_66.3.366.4","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-023-06255-8"},{"key":"2025030410451226000_66.3.366.5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/pros.23444","article-title":"99mTc-MIP-1404-SPECT\/CT for the detection of PSMA-positive lesions in 225 patients with biochemical recurrence of prostate cancer","volume":"78","author":"Schmidkonz","year":"2018","journal-title":"Prostate."},{"key":"2025030410451226000_66.3.366.6","doi-asserted-by":"publisher","DOI":"10.1007\/s12149-019-01400-6"},{"key":"2025030410451226000_66.3.366.7","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264296"},{"key":"2025030410451226000_66.3.366.8","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.241588"},{"key":"2025030410451226000_66.3.366.9","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.198119"},{"key":"2025030410451226000_66.3.366.10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.265242"},{"key":"2025030410451226000_66.3.366.11","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.eururo.2018.11.016","article-title":"Treatment outcome, toxicity, and predictive factors for radioligand therapy with 177Lu-PSMA-I&T in metastatic castration-resistant prostate cancer","volume":"75","author":"Heck","year":"2019","journal-title":"Eur Urol."},{"key":"2025030410451226000_66.3.366.12","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1007\/s00259-022-05744-6","article-title":"Matched-pair analysis of [177Lu]Lu-PSMA I&T and [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer","volume":"49","author":"Hartrampf","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025030410451226000_66.3.366.13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.2702"},{"key":"2025030410451226000_66.3.366.14","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.263262"},{"key":"2025030410451226000_66.3.366.15","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1007\/s00259-023-06332-y","article-title":"Is PSMA PET\/CT cost-effective for the primary staging in prostate cancer? First results for European countries and the USA based on the proPSMA trial","volume":"50","author":"Holzgreve","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025030410451226000_66.3.366.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.11.038"},{"key":"2025030410451226000_66.3.366.17","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.193581"},{"key":"2025030410451226000_66.3.366.18","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.263889"},{"key":"2025030410451226000_66.3.366.19","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1007\/s00259-017-3669-5","article-title":"Comparison of standard and delayed imaging to improve the detection rate of [68Ga]PSMA I&T PET\/CT in patients with biochemical recurrence or prostate-specific antigen persistence after primary therapy for prostate cancer","volume":"44","author":"Schmuck","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025030410451226000_66.3.366.20","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s00259-017-3670-z","article-title":"68Ga-PSMA PET\/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0","volume":"44","author":"Fendler","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025030410451226000_66.3.366.21","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.263441"},{"key":"2025030410451226000_66.3.366.22","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.246983"},{"key":"2025030410451226000_66.3.366.23","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.3390\/cancers13122938","article-title":"PSMA expression predicts early biochemical response in patients with metastatic castration-resistant prostate cancer under 177Lu-PSMA-617 radioligand therapy","volume":"13","author":"Widjaja","year":"2021","journal-title":"Cancers (Basel)."},{"key":"2025030410451226000_66.3.366.24","doi-asserted-by":"crossref","first-page":"e233460","DOI":"10.1148\/radiol.233460","article-title":"Quantitative 68Ga-PSMA-11 PET and clinical outcomes in metastatic castration-resistant prostate cancer following 177Lu-PSMA-617 (VISION trial)","volume":"312","author":"Kuo","year":"2024","journal-title":"Radiology."},{"key":"2025030410451226000_66.3.366.25","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s00259-022-06028-9","article-title":"EANM practice guideline for quantitative SPECT-CT","volume":"50","author":"Dickson","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025030410451226000_66.3.366.26","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S1470-2045(22)00605-2","article-title":"PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial","volume":"23","author":"Buteau","year":"2022","journal-title":"Lancet Oncol."},{"key":"2025030410451226000_66.3.366.27","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1007\/s00259-023-06281-6","article-title":"SUVmean on baseline [18F]PSMA-1007 PET and clinical parameters are associated with survival in prostate cancer patients scheduled for [177Lu]Lu-PSMA I&T","volume":"50","author":"Hartrampf","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025030410451226000_66.3.366.28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s40658-023-00586-z","article-title":"Quantitative 177Lu SPECT\/CT imaging for personalized dosimetry using a ring-shaped CZT-based camera","volume":"10","author":"Danieli","year":"2023","journal-title":"EJNMMI Phys."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.124.269319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T18:46:26Z","timestamp":1741113986000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.124.269319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,3]]},"published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.2967\/jnumed.124.269319"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.124.269319","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,6]]}}}